Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a long non-coding RNA transcribed antisense to the TFF1 gene locus. It shows alternative splicing and contains large segments of the antisense strand from TFF1 introns 1 and 2. No protein product has been identified. Antisense transcription of non-coding RNAs such as this one can regulate the expression of the corresponding sense gene, sometimes through gene silencing or transcriptional interference. No direct evidence links this transcript to therapeutic targeting or disease, and its biological role remains unclear except for a possible regulatory effect in specific tissues. Most of the core information is sourced from databases and primary molecular profiling; there is no evidence this molecule is a canonical, actionable therapeutic target. It is correctly classified as a novel antisense lncRNA rather than a protein-coding gene or classical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to trefoil factor 1 (ENSG00000306128).